Thu Sep 12 07:05:54 UTC 2024: ## Qritive’s AI Prostate Grade Algorithm Integrates with Roche’s Digital Pathology Platform

**Singapore, [Date]** – Qritive, a leading developer of AI-powered pathology solutions, announced today the integration of its QAi Prostate Grade algorithm with Roche’s navify® Digital Pathology platform. This collaboration aims to enhance the performance of pathologists by providing them with AI-powered tools for accurate and affordable diagnostics.

“We are thrilled to see how the integration of our AI solutions within the Roche navify platform will empower pathologists,” said Bruno Occhipinti, CEO of Qritive. “This partnership will enable us to deliver accurate and affordable diagnostics at scale, ultimately improving patient outcomes.”

The integration of Qritive’s AI technology with Roche’s platform provides a significant step forward in the field of digital pathology. By leveraging deep learning algorithms, Qritive’s QAi Prostate Grade algorithm supports pathologists in interpreting pathology tests, enabling faster diagnosis and quicker treatment initiation.

This collaboration reinforces Qritive’s commitment to empowering healthcare professionals globally with state-of-the-art AI solutions. By bringing its innovative technology to a broader audience, Qritive plays a key role in advancing the future of cancer diagnostics.

**About Qritive**

Headquartered in Singapore with operations in the US and India, Qritive develops breakthrough AI solutions to advance digital pathology for cancer diagnosis. The company is dedicated to empowering healthcare professionals worldwide with AI-powered solutions, enabling collaborative work and enhancing performance despite complexity and distance.

For more information, visit http://www.qritive.com or contact [email protected]

Read More